Am still bit curious why IMugene are still holding on not to raise cash? No any biotech company can be such confident to continue a few trials without enough money in bank. While this time imugene sounds really confident without worrying to rashly put out 20% or more discount to raise cash following any of last 4 announcements.
remember last capital raise at 0.2c while they had $150m in bank. So this time with $54m in bank, they are not rashly raising money?? They were keeping calm at agm to talk about current clinic trials and upcoming fda meeting.
They do know something in hand and not to worry.
I would have 4.2c as buy-in to see a big news to be announced.
IMU Price at posting:
4.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)